GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Medmix AG (XSWX:MEDX) » Definitions » 3-Year EPS without NRI Growth Rate

Medmix AG (XSWX:MEDX) 3-Year EPS without NRI Growth Rate : -57.60% (As of Jun. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Medmix AG 3-Year EPS without NRI Growth Rate?

Medmix AG's EPS without NRI for the six months ended in Jun. 2025 was CHF0.06.

During the past 12 months, Medmix AG's average EPS without NRI Growth Rate was -144.70% per year. During the past 3 years, the average EPS without NRI Growth Rate was -57.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 7 years, the highest 3-Year average EPS without NRI Growth Rate of Medmix AG was -2.90% per year. The lowest was -57.60% per year. And the median was -8.40% per year.


Competitive Comparison of Medmix AG's 3-Year EPS without NRI Growth Rate

For the Specialty Industrial Machinery subindustry, Medmix AG's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medmix AG's 3-Year EPS without NRI Growth Rate Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Medmix AG's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Medmix AG's 3-Year EPS without NRI Growth Rate falls into.


;
;

Medmix AG 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Medmix AG  (XSWX:MEDX) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Medmix AG 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Medmix AG's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Medmix AG Business Description

Industry
Traded in Other Exchanges
Address
Neuhofstrasse 20, Baar, CHE, 6340
Medmix AG delivers technologies in high-precision delivery devices and fluid mixing for applications. It is into two business areas Healthcare and Consumer & Industrial. The Healthcare business area is divided into the Dental, Drug Delivery, and Surgery segments. The Consumer & Industrial business area operates through the Industry and Beauty segments. The majority of its revenue is from the Consumer & Industrial segment. In the Industry segment, dispensers, cartridges, and mixers are used in the construction, transportation (automotive, railways, and aerospace), electronics assembly, infrastructure, and DIY industries. Geographically, it operates in Europe the Middle East and Africa, the Americas, and Asia-Pacific.

Medmix AG Headlines